Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.04.008Source: DataRank Database

Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors is a research paper published in Clinical Genitourinary Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

38 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: closedTopics (1)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Archana M. Agarwal ORCID,Moshe Chaim Ornstein ORCID,Jorge García ORCID,Ruby Gupta ORCID,Petros Grivas ORCID

Live enrichment

PubMed:34006497

National Institutes of Health

Grant: FA189447/A15846

Influential Citations

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S1558767321000938?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1558767321000938?httpAccept=text/plain

Fields of Study

Medicine

Additional file 1 of Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

10.6084/m9.figshare.19129124.v1figshare

Additional file 1 of Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

10.6084/m9.figshare.19129124figshare

Additional file 2 of Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

10.6084/m9.figshare.19129127.v1figshare

Additional file 2 of Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

10.6084/m9.figshare.19129127figshare

Additional file 3 of Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

10.6084/m9.figshare.19129130.v1figshare

Additional file 3 of Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

10.6084/m9.figshare.19129130figshare

Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors

FAIR Checklist

Authors (16)

Funding (1 grants)

Impact

Open Access

Topics

Linked Datasets (6)